Understanding hepatitis C virus reinfections in England in the context of eliminating viral hepatitis as a public health concern

Datos Bibliográficos

ID14909294
AutoresMatthew Hibbert (0000-0002-1759-455X, Public Health England, autor de correspondencia), Ross J Harris, Ross Harris (0000-0003-3190-7281, Environment Agency), Caroline Sabin (0000-0001-5173-2760, National Institute for Health and Care Research), Ruth Simmons (0000-0001-8156-0146, National Institute for Health and Care Research), Sema Mandal (0000-0003-3379-3118, National Institute for Health and Care Research), Monica Desai (0000-0001-8632-9808, National Institute for Health and Care Research)
Año2025
Volumen145
Páginas105005
Fecha de publicación2025-11-01
Peer ReviewedSí
Open AccessSí
TipoARTICLE
RevistaInternational Journal of Drug Policy (JOURNAL)
Identificadores de la revistaISSN: 0955-3959 • E-ISSN: 1873-4758
EditorialElsevier BV (PUBLISHER)
DOI10.1016/j.drugpo.2025.105005
PMID40939234
OpenAlexW4414118884
IdiomaEN
Referencias citadas24

HCV reinfection appeared to decrease over the study period, but people were most at risk in the year post-treatment, which remained constant over time. Harm reduction services should be accessible to people who inject drugs and people who have been in prison, particularly soon after treatment

Context (archaeology · Harm · Harm reduction · Hepatitis C · Hepatitis C virus · Public health · Viral hepatitis · Hepatitis B Virus Studies · Hepatitis C virus research · HIV, Drug Use, Sexual Risk